UMIN ID: UMIN000000672
Registered date:05/04/2007
Prediction of drug adverse event through gene expression analysis
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | embedded dens molaris |
Date of first enrollment | 2007/01/01 |
Target sample size | 20 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | Cefcapene Pivoxil Hydrochloride Hydrate 100mg po administration for three times |
Outcome(s)
Primary Outcome | correlation and differences of gene expression between results from basic experiments in vitro and ones in human |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | 60years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | renal dysfunction (Creatinin equal or greater than 2.0 mg/dl) liver dysfunction (ALT, AST, T-bil, LDH or ALP are more than two times greater than upper limit of normal range) confirmed or clinically suspected myocardial infarction and/or congestive heart failure prescribed medicines for diabetes mellitus and/or hypertension pasthistory for hypersensitivities and/or allargic reactions against Cefcapene Pivoxil Hydrochloride Hydrate or ingredients of Flomox(R) Past history of hypersensitivities for Cephalosporins |
Related Information
Primary Sponsor | JICHI MEDICAL UNIVERSITY |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | HEALTH AND LABOUR SCIENCES RESEARCH GRNTS |
Secondary ID(s) |
Contact
public contact | |
Name | |
Address | Japan |
Telephone | 0285-58-7550 |
Affiliation | Jichi Medical University SCHOOL AFFAIRS SECTION |
scientific contact | |
Name | Akio Fujimura, MD, PhD |
Address | Shimotsuke-si, Tochigi-ken Japan |
Telephone | |
Affiliation | Jichi Medical University Clinical Pharmacology |